Liquidia Corp

-0.06 (-1.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)123.27M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.73 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$3.03
50-Day MA$2.72
200-Day MA$2.80
See more pivots

Liquidia Corp Stock, NASDAQ:LQDA

419 Davis Drive, Suite 100, Morrisville, North Carolina 27560
United States of America
Phone: +1.919.328.4400
Number of Employees:


Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.